Checking tumor margins during breast cancer surgery
Part of Cancer, Skin clinical trials.
This study tests a new imaging tool that helps surgeons see if any cancer cells are left behind during a lumpectomy. It may reduce the need for a second surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ductal carcinoma in situ (DCIS) or invasive breast cancer from a biopsy
- You are scheduled to have a lumpectomy (breast-conserving surgery)
- You can and will agree to participate in writing
- You do not have advanced (stage III/IV) or metastatic breast cancer
- You have not had chemotherapy before surgery (neoadjuvant chemotherapy)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a scanner (Histolog®) that checks the edges of removed breast tissue during surgery to make sure all cancer is removed. The goal is to reduce the need for a second surgery.
This trial tests a new high-resolution PET/CT scanner used during breast-conserving surgery to check if all cancer has been removed. It aims to reduce the need for repeat surgeries by giving surgeons real-time feedback on tumor margins.
This study tests a small implantable “marker” system (used to help doctors find the tumor or lymph node during breast surgery) for people with breast or lymph node areas that can’t be felt. It may help surgery planning and accuracy when the cancer can’t be easily located by touch.
This trial is testing a new way to identify cancer tissue during breast surgery. It may help surgeons remove cancer more completely during a lumpectomy.
This trial tests a microscope-like scanner that helps surgeons see if all cancer cells have been removed during breast-conserving surgery. It may reduce the need for a second surgery by checking the removed tissue immediately.
This study compares two ways surgeons take “margin” samples (tissue from the edge of the tumor area) during breast-conserving surgery for early breast cancer. It uses a guidance device to help collect these samples and aims to see which approach better supports safe, effective treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.